News + Filings Transactions
|
AHMED NADIM
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/28/2023 | Cullinan Oncology, Inc. | | Sale | Common Stock | 759 | $11.40 | $8.7k | | 06/28/2023 |
| 05/23/2023 | Cullinan Oncology, Inc. | | Sale | Common Stock | 707 | $9.15 | $6.5k | | 05/23/2023 |
| 03/23/2023 | Cullinan Oncology, Inc. | | Sale | Common Stock | 706 | $10.51 | $7.4k | | 03/23/2023 |
| 02/22/2023 | Cullinan Oncology, Inc. | | Grant | Common Stock | 109k | $0.00 | $0 | | 02/22/2023 |
| 02/22/2023 | Cullinan Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 211k | $11.03 | $2.3M | | 02/22/2023 |
| 06/30/2022 | Cullinan Oncology, Inc. | | Grant | | 1.6k | $10.90 | $17.7k | | 06/30/2022 |
| 06/06/2022 | Cullinan Oncology, Inc. | | Purchase | Common Stock | 8.1k | $12.40 | $100.3k | | 06/06/2022 |
| 03/05/2022 | Cullinan Oncology, Inc. | | Grant | Performance Stock Unit | 215k | $0.00 | $0 | | 03/05/2022 |
| 10/18/2021 | Cullinan Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 2.7M | $21.12 | $57.2M | | 10/18/2021 |
| 12/31/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 14.9k | $0.00 | $0 | | 12/31/2020 |
| 12/31/2020 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 7.7k | $62.03 | $475.1k | | 12/31/2020 |
| 12/02/2020 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 3.4k | $62.18 | $210.2k | | 12/02/2020 |
| 12/02/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 6.6k | $0.00 | $0 | | 12/02/2020 |
| 10/30/2020 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 2.3k | $58.45 | $133.9k | | 10/30/2020 |
| 10/30/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 4.6k | $0.00 | $0 | | 10/30/2020 |
| 05/01/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 2.9k | $0.00 | $0 | | 05/01/2020 |
| 05/01/2020 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 1.4k | $60.26 | $86.4k | | 05/01/2020 |
| 03/10/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Market Share Units | 21.4k | $0.00 | $0 | | 03/10/2020 |
| 03/10/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Performance Shares | 32.1k | $0.00 | $0 | | 03/10/2020 |
| 03/01/2020 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 8.5k | $59.06 | $500.4k | | 03/01/2020 |
| 03/01/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 17.2k | $0.00 | $0 | | 03/01/2020 |
| 02/04/2020 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 1.1k | $64.29 | $68.9k | | 02/04/2020 |
| 02/04/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 2.1k | $0.00 | $0 | | 02/04/2020 |
| 12/02/2019 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Restricted Stock Units | 26.4k | $0.00 | $0 | | 12/02/2019 |
| 11/20/2019 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Restricted Stock Units | 14.9k | $0.00 | $0 | | 11/20/2019 |
| 11/20/2019 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Restricted Stock Units | 33.2k | $0.00 | $0 | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Grant | Common Stock | 8k | $0.00 | $0 | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Grant | Common Stock | 17.8k | $0.00 | $0 | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Common Stock | 40.7k | $0.00 | $0 | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Common Stock | 2k | $0.00 | $0 | 401(k) Plan | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Stock Option (right to buy) | 1.8k | $36.36 | $63.6k | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Stock Option (right to buy) | 5.6k | $36.47 | $205.1k | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Stock Option (right to buy) | 5.6k | $36.68 | $206.4k | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Stock Option (right to buy) | 9k | $40.22 | $362k | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Stock Option (right to buy) | 5.6k | $49.48 | $278.4k | | 11/20/2019 |
|
|